Stool-sample capsules to study gut microbiome in unexplained atherosclerosis
Treatments studied
Part of Heart & circulation clinical trials.
This early-phase study tests whether taking stool-based capsules can change gut bacteria in people with severe atherosclerosis that can’t be explained by usual risk factors. Researchers also measure related metabolic (body chemistry) and microbiome (gut bacteria) changes to see how this approach might help.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have severe atherosclerosis, meaning your plaque amount is in the top 25% (over 119 mm²).
- Your atherosclerosis is not explained by usual risk factors on risk-factor testing (residual score 2 or higher).
- You are willing and able to sign informed consent after the study is explained.
- You can commit to taking the stool capsules at the start of the study (baseline).
- Your kidneys are functioning well enough (eGFR 50 or higher).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at your gut bacteria (from a stool sample) to see whether they can help predict heart risk in people being checked for blocked heart arteries. Your results may help researchers understand who is at higher risk and why.
This study looks at how the bacteria in your gut might be linked to a heart condition called aortic stenosis, where the heart's main valve becomes stiff and narrow. By comparing people with and without this condition, researchers hope to find new ways to treat it.
This early-stage study tests whether changing the gut bacteria using an oral stool-based treatment (called oral FMT) can improve health in older adults. It aims to see if this approach affects aging-related changes, including gut and body function.
This Phase 2 study tests whether taking capsule stool (FMT) is safe and can help people who are newly diagnosed and haven’t started the usual medicines yet. Participants will also start the standard first-line treatment for their condition, and the study will compare safety and outcomes.
This trial tests whether taking capsules containing processed healthy donor stool (fecal microbiota transplant) can safely remove certain drug-resistant bacteria (like CRE, ESBL-E, and VRE) from your intestines. It may be an option for people who have these bacteria in their stool but are not currently being treated with antibiotics.
This trial tests whether transferring healthy gut bacteria from a donor to patients with rheumatoid arthritis that hasn't improved on standard medications can reduce joint pain and swelling. The goal is to see if rebalancing the gut microbiome (the community of bacteria in your intestines) helps control inflammation.
Hear when a new Atherosclerosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.